Joo‐Hee Yi
Impact in
- Oncology top 2%
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
- Cancer Treatment and Pharmacology
-
- Monoclonal and Polyclonal Antibodies Research
Papers in
- Oncology 12
- HER2/EGFR in Cancer Research 12
- Peptidase Inhibition and Analysis 3
-
- Monoclonal and Polyclonal Antibodies Research 5
- Co-authors
- Sandhya Girish (10 shared papers)Howard A. Burris (6 shared papers)Ian E. Krop (3 shared papers)Scott N. Holden (2 shared papers)Jay Tibbitts (2 shared papers)Shanu Modi (3 shared papers)Muralidhar Beeram (2 shared papers)Ola M. Saad (5 shared papers)
- Journals
- Bioanalysis (3 papers)Cancer Research (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)Journal of Clinical Oncology (1 paper)Toxicology and Applied Pharmacology (1 paper)
- Partner nations
- United StatesSwitzerlandFrance
In The Last Decade
Joo‐Hee Yi
14 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 81
- Oncology 878
- Radiology, Nuclear Medicine and Imaging 622
- Genetics 85
- Biomaterials 107
- Immunology and Allergy 32
Countries citing papers authored by Joo‐Hee Yi
This map shows the geographic impact of Joo‐Hee Yi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joo‐Hee Yi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joo‐Hee Yi more than expected).
Fields of papers citing papers by Joo‐Hee Yi
This network shows the impact of papers produced by Joo‐Hee Yi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joo‐Hee Yi. The network helps show where Joo‐Hee Yi may publish in the future.
Co-authors
The 25 scholars most cited alongside Joo‐Hee Yi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 440 | |
| 2 | 2002 | 213 | |
| 3 | 2012 | 199 | |
| 4 | 2013 | 140 | |
| 5 | 2014 | 65 | |
| 6 | 2011 | 57 | |
| 7 | 2013 | 50 | |
| 8 | 2013 | 39 | |
| 9 | 2013 | 34 | |
| 10 | 2013 | 32 | |
| 11 | 2012 | 30 | |
| 12 | 2012 | 26 | |
| 13 | 2009 | 3 | |
| 14 | 2015 | 1 |
About Joo‐Hee Yi
Joo‐Hee Yi is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine, Molecular Biology and Immunology and Allergy, having authored 14 papers that have together received 1.3k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (12 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Peptidase Inhibition and Analysis (3 papers), Cell Adhesion Molecules Research (1 paper), Angiogenesis and VEGF in Cancer (1 paper), Breast Cancer Treatment Studies (1 paper), Lung Cancer Treatments and Mutations (1 paper) and Advanced Breast Cancer Therapies (1 paper). The work is most often cited by research in Oncology (878 citations), Radiology, Nuclear Medicine and Imaging (622 citations), Genetics (85 citations), Biomaterials (107 citations) and Immunology and Allergy (32 citations). Joo‐Hee Yi has collaborated with scholars based in United States, Switzerland and France. Frequent co-authors include Sandhya Girish, Howard A. Burris, Ian E. Krop, Scott N. Holden, Jay Tibbitts, Shanu Modi, Muralidhar Beeram, Ola M. Saad, Stuart Lutzker and Wei Yu. Their work appears in journals such as Bioanalysis, Cancer Research, Cancer Chemotherapy and Pharmacology, Journal of Clinical Oncology and Toxicology and Applied Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.